Paper20133865
Spatiotemporal controlled delivery of nanoparticles to injured vasculature.
Chan JM and 13 others. Proc Natl Acad Sci U S A, 2010. Cited by 178 papers, by iCite.
Cite this record
ConductScience Library. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Papers, record 20133865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20133865
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Vessels | Major topic |
| Drug Delivery Systems | Major topic |
| Nanoparticles | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antigens | |
| Biomedical Engineering | |
| Cells, Cultured | |
| Delayed-Action Preparations | |
| Humans | |
| Muscle, Smooth, Vascular | |
| Nanomedicine | |
| Paclitaxel | |
| Peptide Library | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA119349 | NCI NIH HHS | United States | U54CA119349 | PubMed and NIH | NIH RePORTER |
| K08 EB003647 | NIBIB NIH HHS | United States | K08EB003647 | PubMed and NIH | NIH RePORTER |
| EB003647 | NIBIB NIH HHS | United States | K08EB003647 | PubMed and NIH | NIH RePORTER |
| R21 CA139329 | NCI NIH HHS | United States | R21CA139329 | PubMed and NIH | NIH RePORTER |
| U54 CA119349 | NCI NIH HHS | United States | U54CA119349 | PubMed and NIH | NIH RePORTER |
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15173077 | Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15173077 | PubMed |
| 2 | 12646012 | Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. | AAPS PharmSci | 2002 | https://conductscience.org/library/papers/12646012 | PubMed |
| 3 | 11457057 | Polymerization of lactide with zinc and magnesium beta-diiminate complexes: stereocontrol and mechanism. | J Am Chem Soc | 2001 | https://conductscience.org/library/papers/11457057 | PubMed |
| 4 | 11848876 | Phage Display. | Chem Rev | 1997 | https://conductscience.org/library/papers/11848876 | PubMed |
| 5 | 11557668 | Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11557668 | PubMed |
| 6 | 17396134 | Angiogenesis: an organizing principle for drug discovery? | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17396134 | PubMed |
| 7 | 8128245 | Biodegradable long-circulating polymeric nanospheres. | Science | 1994 | https://conductscience.org/library/papers/8128245 | PubMed |
| 8 | 19332089 | Extracellular matrix binding mixed micelles for drug delivery applications. | J Control Release | 2009 | https://conductscience.org/library/papers/19332089 | PubMed |
| 9 | 19525947 | Understanding biophysicochemical interactions at the nano-bio interface. | Nat Mater | 2009 | https://conductscience.org/library/papers/19525947 | PubMed |
| 10 | 19805309 | Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19805309 | PubMed |
| 11 | 16670444 | Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: six-month clinical and angiographic follow-up results of the APPLAUSE trial. | J Invasive Cardiol | 2006 | https://conductscience.org/library/papers/16670444 | PubMed |
| 12 | 18654426 | Nanocarriers as an emerging platform for cancer therapy. | Nat Nanotechnol | 2007 | https://conductscience.org/library/papers/18654426 | PubMed |
| 13 | 18672949 | Factors affecting the clearance and biodistribution of polymeric nanoparticles. | Mol Pharm | 2008 | https://conductscience.org/library/papers/18672949 | PubMed |
| 14 | 18491339 | Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles. | Angew Chem Int Ed Engl | 2008 | https://conductscience.org/library/papers/18491339 | PubMed |
| 15 | 19657379 | Alternative splicing and biological heterogeneity in prostate cancer. | Nat Rev Urol | 2009 | https://conductscience.org/library/papers/19657379 | PubMed |
| 16 | 18758474 | Nanoparticle therapeutics: an emerging treatment modality for cancer. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18758474 | PubMed |
| 17 | 18246072 | Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. | Nat Mater | 2008 | https://conductscience.org/library/papers/18246072 | PubMed |
| 18 | 17957183 | Nanoparticles in medicine: therapeutic applications and developments. | Clin Pharmacol Ther | 2008 | https://conductscience.org/library/papers/17957183 | PubMed |
| 19 | 8253711 | Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8253711 | PubMed |
| 20 | 11452024 | Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. | Nucleic Acids Res | 2001 | https://conductscience.org/library/papers/11452024 | PubMed |
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948745 | Remodeling macrophage efferocytosis and phenotype via targeted nanoimmunotherapy for atherosclerosis. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42948745 | PubMed |
| 42799491 | Tunable regional targeting of self-assembling peptide nanomaterials in acute myocardial infarction. | Adv Nanobiomed Res | 2026 | https://conductscience.org/library/papers/42799491 | PubMed |
| 41634764 | Macrophage pyroptosis inhibition alleviates postinjury neointimal formation and vascular restenosis. | J Transl Med | 2026 | https://conductscience.org/library/papers/41634764 | PubMed |
| 40843286 | Evaluation of a Targeted Drug-Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model. | Adv Nanobiomed Res | 2021 | https://conductscience.org/library/papers/40843286 | PubMed |
| 40442906 | Type IV Collagen-Targeting Nanoparticles for Efficient Delivery to the Renal Interstitium in Fibrotic Kidneys. | Curr Drug Deliv | 2026 | https://conductscience.org/library/papers/40442906 | PubMed |
| 40143044 | Oral Bioavailability Enhancement of Anti-Cancer Drugs Through Lipid Polymer Hybrid Nanoparticles. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40143044 | PubMed |
| 39587209 | Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery. | Sci Rep | 2024 | https://conductscience.org/library/papers/39587209 | PubMed |
| 39439489 | Deformable nanocarriers for enhanced drug delivery and cancer therapy. | Exploration (Beijing) | 2024 | https://conductscience.org/library/papers/39439489 | PubMed |
| 38930939 | Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis. | Molecules | 2024 | https://conductscience.org/library/papers/38930939 | PubMed |
| 38525311 | Simultaneous fingerprinting of multiplex collagen biomarkers in connective tissues by multicolor quantum dots-based peptide probes. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/38525311 | PubMed |
| 37404681 | Atherosclerosis treatment with nanoagent: potential targets, stimulus signals and drug delivery mechanisms. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/37404681 | PubMed |
| 37063777 | Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/37063777 | PubMed |
| 37033603 | Lipid-engineered nanotherapeutics for cancer management. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37033603 | PubMed |
| 36733971 | Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/36733971 | PubMed |
| 35851660 | Recent advancements in enzyme-incorporated nanomaterials: Synthesis, mechanistic formation, and applications. | Biotechnol Bioeng | 2022 | https://conductscience.org/library/papers/35851660 | PubMed |
| 35356091 | Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies. | J Tissue Eng | 2022 | https://conductscience.org/library/papers/35356091 | PubMed |
| 34870408 | Targeting the Extracellular Matrix in Traumatic Brain Injury Increases Signal Generation from an Activity-Based Nanosensor. | ACS Nano | 2021 | https://conductscience.org/library/papers/34870408 | PubMed |
| 34867370 | Nanotechnology for Targeted Therapy of Atherosclerosis. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34867370 | PubMed |
| 34834231 | Liposomal Nanocarriers Designed for Sub-Endothelial Matrix Targeting under Vascular Flow Conditions. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834231 | PubMed |
| 34616741 | Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34616741 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20133865
GET https://conductscience.org/api/papers/v1/20133865/references?page=2